VANCOUVER, BC — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of the… Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) a leading global medical technology company, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne… Read More
Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.- United Therapeutics Corporation announced the first clinical xenotransplantation in… Read More
Dupixent is the first new targeted therapy in over a decade for people aged 12 years and older living with CSU who remain symptomatic despite H1 antihistamine treatment Approval based… Read More
WELLSTAR enters into subscription agreements to complete a C$62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR… Read More
